Theravance Biopharma TBPH Business Segments — Nonoperating Income Expense Milestone Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept tbph:NonoperatingIncomeExpenseMilestoneIncome.
The official record: Theravance Biopharma’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's business segments — nonoperating income expense milestone income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's business segments — nonoperating income expense milestone income?
- Theravance Biopharma (TBPH) reported business segments — nonoperating income expense milestone income of $12.5M in Q4 2025.
- What does business segments — nonoperating income expense milestone income mean?
- This represents revenue or income recognized upon the achievement of specific contractual milestones, such as regulatory approvals or development targets. It is a key indicator of the segment's success in advancing its pipeline and the effectiveness of its partnership or licensing agreements.